Continuous HUMINT-driven monitoring of competitor pipelines, trials, and narratives. Weekly and quarterly readouts translate early signals into clear, time-bound implications for your leadership team.
End-to-end market assessment across assets, mechanisms, and indications. We quantify competitive pressure, forecast behavioral adoption, and define market entry inflection points.
Cross-functional playbooks for pre-launch positioning, payer sequencing, and medical engagement. We fuse behavioral insights with channel economics to drive disciplined execution.
Custom field intelligence to test hypotheses, validate strategic assumptions, and surface competitive blind spots. Every interview is anonymized, forensically sovereign, and auditable.
Sustained growth, client retention and strategic thought partnership
Global boots on the ground, with diverse teams who are fluent in 17 languages
Our team brings together deep domain expertise and sharp communication to make complex biopharma strategy clear, actionable, and impactful.
Driven by Experts
Aligned by Design
Powered by Values
Current and recent operators with role relevant perspectives.
Artificial, machine, and deep learning that structure unstructured inputs and expose contradiction.
One cadence that turns noise into decision grade insight.
Project Φ.X, research series, and field informed analysis for biopharma leaders.
